Drug Profile
Research programme: G protein-coupled receptor modulators - Domain Therapeutics/XOMA
Latest Information Update: 28 Mar 2018
Price :
$50
*
At a glance
- Originator Domain Therapeutics; XOMA
- Class Antibodies
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for research development in Undefined in France
- 28 Mar 2018 No recent reports of development identified for research development in Undefined in USA
- 04 Feb 2014 Early research in Undefined indication in USA and France (unspecified route)